Skip to main content
Kothari Fermanatation & Biochem Ltd logo

Kothari Fermanatation & Biochem Ltd — Investor Relations & Filings

Ticker · 507474 ISIN · INE991B01010 BSE.NS Manufacturing
Open in API
Filings indexed 323 across all filing types
Latest filing 2021-06-30 Regulatory Filings
Country IN India
Listing BSE.NS 507474

About Kothari Fermanatation & Biochem Ltd

https://www.kothariyeast.in

Kothari Fermentation & Biochem Ltd specializes in the production of yeast and yeast-based derivatives through advanced fermentation technology. The company's primary product portfolio includes compressed yeast, dried yeast, and instant dry yeast, marketed under the brand name Sunrise. These products cater extensively to the bakery and food processing industries. Additionally, the firm operates in the biochemical sector, producing industrial alcohol, extra neutral alcohol, and rectified spirits. Utilizing integrated manufacturing processes, the company focuses on high-quality biochemical solutions for diverse industrial applications, including the beverage and pharmaceutical sectors. Its operations emphasize technical precision in fermentation to ensure product consistency and performance in commercial baking and industrial fermentation processes.

Recent filings

Filing Released Lang Actions
This is to inform you that pursuant to the provisions of the Securities And Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company's code of conduct ....
Regulatory Filings
2021-06-30 English
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the Company has issued duplicate share certificate.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Bombay Stock Exchange regarding the issuance of a duplicate share certificate under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It provides details of the duplicate share certificate issued to a shareholder. The document is an official notification related to share certificates and compliance with listing regulations, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial data. The document is a regulatory announcement informing the exchange and public about the issuance of duplicate share certificates, fitting the category of Regulatory Filings (RNS). The document length is short (1644 characters), and it is not an announcement of a report publication but a direct regulatory notification.
2021-06-14 English
With reference to your email dated 24th May, 2021 regarding clarification on price movement, we would like to clarify that, any movement in the volume/price at the Stock Exchange is not ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Bombay Stock Exchange regarding a clarification on price movement of the company's stock. It explicitly states that the price movement is due to external market factors and not under company control. The letter references compliance with SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, and mentions future disclosures as per Regulation 30. The document is short (1346 characters) and serves as a regulatory communication or clarification rather than a financial report or announcement of a report. It does not contain financial data, management changes, voting results, or other specific report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance communications that do not fit other categories.
2021-06-02 English
We are hereby submitting the Compliance Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 issued by the practicing Company Secretary ....
Regulatory Filings Classification · 95% confidence The document is a Compliance Certificate issued under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended 31st March 2021. It is signed by a practicing Company Secretary and certifies share transfer activities (or lack thereof) during the period. The document is short (2390 characters) and is a certificate of compliance rather than a full financial or management report. It does not contain financial statements or detailed analysis. This type of certificate is a regulatory filing related to compliance with listing obligations, not an annual or interim report, audit report, or other specific report types. Therefore, it fits best under Regulatory Filings (RNS).
2021-04-27 English
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we wish to state that CRISIL Ratings has revised the outlook and reaffirmed the credit Ratings to the bank facilities as under: ....
Regulatory Filings
2021-04-19 English
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we are enclosing herewith a copy of the Certificate received from M/s Abhipra Capital Limited, ....
Regulatory Filings
2021-04-07 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.